InnoTek Limited
InnoTek Limited (M14.SI) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for InnoTek Limited (M14.SI), featuring income statements, balance sheets, and cash flow data.
InnoTek Limited (M14.SI) Income Statement & Financial Overview
View the income breakdown for InnoTek Limited M14.SI across both annual and quarterly reports.
| Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $60.79M | $60.79M | $56.35M | $56.35M |
| Cost of Revenue | $51.94M | $51.94M | $47.70M | $47.70M |
| Gross Profit | $8.85M | $8.85M | $8.65M | $8.65M |
| Gross Profit Ratio | $0.15 | $0.15 | $0.15 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $8.15M | $8.15M | $7.37M | $7.37M |
| Operating Expenses | $8.15M | $8.15M | $7.37M | $7.37M |
| Total Costs & Expenses | $60.09M | $60.09M | $55.07M | $55.07M |
| Interest Income | $0.00 | $0.00 | $940000.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $1.13M | $0.00 |
| Depreciation & Amortization | $1.35M | $1.35M | $1.28M | $1.28M |
| EBITDA | $2.04M | $2.04M | $2.56M | $2.56M |
| EBITDA Ratio | $0.03 | $0.03 | $0.05 | $0.05 |
| Operating Income | $697500.00 | $697500.00 | $1.28M | $1.28M |
| Operating Income Ratio | $0.01 | $0.01 | $0.02 | $0.02 |
| Other Income/Expenses (Net) | $1.23M | $1.23M | $1500.00 | $1500.00 |
| Income Before Tax | $1.93M | $1.93M | $1.28M | $1.28M |
| Income Before Tax Ratio | $0.03 | $0.03 | $0.02 | $0.02 |
| Income Tax Expense | $372000.00 | $372000.00 | $657500.00 | $657500.00 |
| Net Income | $1.58M | $1.58M | $608000.00 | $608000.00 |
| Net Income Ratio | $0.03 | $0.03 | $0.01 | $0.01 |
| EPS | $0.007 | $0.007 | $0.003 | $0.003 |
| Diluted EPS | $0.007 | $0.007 | $0.003 | $0.003 |
| Weighted Avg Shares Outstanding | $231.91M | $231.91M | $233.85M | $233.85M |
| Weighted Avg Shares Outstanding (Diluted) | $231.31M | $231.31M | $231.31M | $231.31M |
The company's financials show resilient growth, with revenue advancing from $56.35M in Q3 2023 to $60.79M in Q2 2024. Gross profit remained healthy with margins at 15% in Q2 2024 compared to 15% in Q3 2023. Operating income hit $697500.00 last quarter, sustaining a consistent 1% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.04M. Net income rose to $1.58M, while earnings per share reached $0.007. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan